[1]
2025. COMPARISON OF ANTI-MICROBIAL SUSCEPTIBILITY OF AZITHROMYCIN AND LEVOFLOXACIN AGAINST Pseudomonas aeruginosa AND Salmonella typhi. The Research of Medical Science Review. 3, 9 (Sep. 2025), 119–126.